NDC 63851-501

RabAvert

Rabies Vaccine

RabAvert is a Kit in the Vaccine category. It is labeled and distributed by Gsk Vaccines Gmbh. The primary component is .

Product ID63851-501_1e6d0596-d032-4f29-a94b-ca5ce32abe23
NDC63851-501
Product TypeVaccine
Proprietary NameRabAvert
Generic NameRabies Vaccine
Dosage FormKit
Marketing Start Date2014-07-08
Marketing End Date2020-03-31
Marketing CategoryBLA / BLA
Application NumberBLA103334
Labeler NameGSK Vaccines GmbH
Active Ingredient Strength0
NDC Exclude FlagN

Packaging

NDC 63851-501-02

1 KIT in 1 CARTON (63851-501-02) * 1 mL in 1 SYRINGE (63851-512-12) * 1 mL in 1 VIAL, GLASS (63851-511-11)
Marketing Start Date2014-07-08
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 63851-501-02 [63851050102]

RabAvert KIT
Marketing CategoryBLA
Application NumberBLA103334
Product TypeVACCINE
Billing UnitEA
Marketing Start Date2014-11-10
Marketing End Date2020-03-31

NDC 63851-501-01 [63851050101]

RabAvert KIT
Marketing CategoryBLA
Application NumberBLA103334
Product TypeVACCINE
Billing UnitEA
Marketing Start Date2014-07-08
Marketing End Date2014-11-10

Drug Details

NDC Crossover Matching brand name "RabAvert" or generic name "Rabies Vaccine"

NDCBrand NameGeneric Name
50090-1820RabAvertRabies Vaccine
50090-3096RabAvertRabies Vaccine
50632-010RabAvertRabies Vaccine
58160-964RabAvertRabies Vaccine
63851-501RabAvertRabies Vaccine

Trademark Results [RabAvert]

Mark Image

Registration | Serial
Company
Trademark
Application Date
RABAVERT
RABAVERT
79301264 not registered Live/Pending
BAVARIAN NORDIC A/S
2020-10-16
RABAVERT
RABAVERT
75172869 2200256 Live/Registered
GSK VACCINES GMBH
1996-09-27

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.